|[September 05, 2013]
BIO-Europe® 2013 Program is Packed with Well-Known Dealmakers
ZURICH & VIENNA --(Business Wire)--
Pharmaceutical executives and leaders in biotech are on board to speak
at the 19th annual BIO-Europe® international partnering
conference in Vienna, Austria, November 4-6, 2013. Organized by EBD
Group in collaboration with the Biotechnology Industry Organization and
local host Life Science Austria Vienna (LISAvienna), the event is
Europe's largest partnering conference serving the global biotechnology
The event is built upon the one-to-one partnering meetings powered by
the life science industry's leading networking solution, partneringONE®.
With partneringONE, partnering meetings at BIO-Europe in Vienna can be
scheduled prior to the event, and will be the main focus of activity on
site. BIO-Europe also features a robust program focused on topics
relevant to industry executives, and ranges from panels and workshops to
keynote addresses and industry presentations.
The high caliber of executive speakers from the life sciences,
complemented with timely program topics, draws delegates to BIO-Europe
every year. In 2012, the Hamburg, Germany edition was attended by 2,957
delegates representing 52 countries. Delegates had access to 3,028
projects available for partnering, and over 15,000 one-to-one partnering
meetings were held.
Parallel workshops kick off the first day, and topics range from
collaborative approaches to translational research, to licensing issues
Stefan Frings, Global Head of Oncology/Immuno-Oncology at Roche
Partnering, is a panelist on "Personalized medicine in oncology:
Turning away from the 'one size fits all' therapy?" taking place Monday
morning, November 4. "A personalized approach to drug treatment is an
important improvement to cancer patient outcomes," said Frings.
"But the slow pace of getting customized treatments, including the
associated diagnostic from bench to bedside and to be embraced by
payers, is an issue. At BIO-Europe, leaders in oncology will come
together to discuss personalized medicine and its application to the
future of cancer research."
A big draw every year are the parallel panel discussions in the
Spotlight and Business Development Tracks. James O'Mara, VP,
Corporate Development at Ironwood Pharmaceuticals is a panelist on
"How to position your asset for the optimal deal," to take place on
Monday afternoon. "The barometer of success is always the deal.
Did you get the deal and how much was it worth?" said O'Mara. "But the
real question is what has the deal done for your company? If you don't
have a compelling answer to that question then you have done the wrong
The second day features a Keynote plenary entitled "A day in the life of
experienced dealmakers: Transformational deals that shaped the industry
in 2013" with panelists from big pharma. Panelist James Sabry, Senior
VP and Global Head of Genentech Partnering, said, "There was
significant deal activity in the first quarter of 2013, and these were
driven by several large transactions. This was followed by a 'quality
over quantity' trend where we have seen less deal value but increased
innovation. We will review that activity and discuss the outlook for the
fourth quarter and 2014 especially in light of the current IPO market."
Presenting companies at BIO-Europe provide direct access to innovation
in the sector. New to the presenting companies track this year is the
addition of an Academic Innovators™ Showcase. In response to
pharma's interest in increased access to academia, the showcase is
designed to shine a spotlight on extraordinary scientific advances with
strong translational potential. The Academic Innovators Showcase
features presentations from nonprofit universities, institutes and
hospitals who are actively conducting preclinical research within a
Information for BIO-Europe can be found online at http://www.ebdgroup.com/bioeurope.
LISAvienna - Life Science Austria Vienna is the life science cluster
organization of the City of Vienna, serving all stakeholders in the
areas of biotechnology/pharmaceuticals and medical technology.
As a joint initiative of the Republic of Austria and the City of Vienna,
LISAvienna helps to ensure that the economic potential of life sciences
is put to good use and turned into marketable products, improved
processes and new services. The main focus of its activities is on
custom-tailored advice and assistance for innovative enterprises.
LISAvienna is supported by Austria Wirtschaftsservice GmbH (aws) and the
ZIT - The Technology Agency of the City of Vienna.
About BIO-Europe 2013
The 19th annual BIO-Europe® event will be the largest biotechnology
partnering conference held in Europe. Over 3,000 global decision makers
from biotechnology, pharma and finance, representing upwards of 1,700
companies from over 50 countries, annually attend BIO-Europe to identify
new business opportunities and develop strategic relationships.
BIO-Europe features the industry's most advanced web-based partnering
system enabling delegates from all parts of the biotechnology value
chain to quickly identify, engage and enter into strategic relationships
that drive their business successfully forward. BIO-Europe will take
place November 4-6, 2013 in Vienna, Austria.
Follow BIO-Europe 2013 on Twitter (News - Alert): twitter.com/ebdgroup
Notes to Editors:
Entry to BIO-Europe 2013 is free to members of the press, including full
access to the partnering system, sessions, press conferences, workshops,
and pre-arranged partnering meetings. Visit the BIO-Europe conference
website at http://www.ebdgroup.com/bioeurope/registration/press_reg.php
for registration details.
About EBD Group
EBD Group is the leading partnering firm for the global life science
industry. Since 1993, biotech, pharma and medical device companies have
leveraged EBD Group's partnering conferences, technology and services to
identify business opportunities and develop strategic relationships
essential to their success.
EBD Group's conferences are run with the support of leading corporations
and international trade associations and include:
BIO-Europe Spring®, Europe's largest life science partnering
conferences, supported by the Biotechnology Industry Organization (BIO)
America™, the fastest growing partnering event in North America
Showcase™, a unique forum in San Francisco for presenting to
investors and business development executives, co-produced with
Demy-Colton Life Science Advisors
Europe, the investor conference co-organized with BioCentury
Publications and BIO
Partnering Forum, the first dedicated biotech/pharma partnering
conference in China, co-produced with ChinaBio® LLC
EBD Group's partnering event for the innovative medical technology
for Global Impact®, an inspirational partnering conference
providing an innovative forum to partner, identify and generate social
and philanthropic investment and funding opportunities
EBD Group's sophisticated web-based partnering service, partneringONE®,
is used as the partnering engine at numerous third-party events around
the world, and partnering360® is the open
online community of life science dealmakers that enhances partnering
experiences throughout the year.
EBD Group is an Informa (News - Alert) company. Informa is the largest publicly-owned
organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130905006239/en/
[ Back To Technology News's Homepage ]